Últimos Artículos de Diabetes, Obesity and Metabolism

- What Would Show That Strength Is Preserved During Semaglutide Weight Loss?
- Real‐World Initiation of Resmetirom and Recorded Incretin Exposure in the United States
- Impact of Different Meal Types and Macronutrients on Circulating FGF21 and Appetite in Humans: A Systematic Review of Randomized Trials
- Association of Continuous Glucose Monitoring‐Based Nocturnal Glucose Patterns With Microvascular Complications in Patients With Type 2 Diabetes
- Endoscopic Ultrasound‐Guided Bypass Reversal for Postprandial Reactive Hypoglycaemia After Roux‐En‐Y Gastric Bypass Surgery: Results of a Prospective Pilot Study
- GLP‐1(9‐37) Improves Left Ventricular Function in a Murine Model of Cardiac Pressure Overload by Promoting Mitochondrial Biogenesis
- Comparison of Sensor Accuracy for Three Different CGM‐Systems Using Either Displayed or Auto‐Logged Values in Individuals With Type 1 Diabetes Mellitus
- Efficacy and Safety of Anagliptin Added to Metformin and Empagliflozin 10 mg in Korean Adults With Type 2 Diabetes: A Multicentre, Randomised, Double‐Blind, Placebo‐Controlled Phase III Trial
- MCP‐1 as a Biomarker of Vascular Function
- Urinary Metabolic and Hemodynamic Protein Signatures in Canagliflozin Treated Patients With Diabetic Kidney Disease: Findings From CREDENCE
- A Cost‐Effectiveness Analysis of FreeStyle Libre Real‐Time Continuous Glucose Monitoring System Compared With Self‐Monitoring of Blood Glucose in Adults With Type 2 Diabetes on Basal Insulin Plus SGLT2 Inhibitor and/or GLP‐1 Agonists in the United Kingdom
- Pre‐Treatment Biomarkers Associated With Remission of Type 2 Diabetes in Response to Short‐Term Insulin‐Based Therapy
- Societal and Economic Burden of Type 1 Diabetes Across Disease Stages in Italy
- Polygenic Risk for Type 2 Diabetes, Multiple Risk Factor Control and Cardiovascular and Non‐Cardiovascular Mortality
- Diurnal Patterns of Accelerometer‐Measured Physical Activity, Genetic Risk and Incident Obesity: A Cohort Study of 58 877 Participants
- Ursodeoxycholic Acid Prophylaxis During Incretin‐Based Obesity Management: An Evidence Gap Worth Addressing?
- Validation of the Progression Likelihood Score (PLS) for Stratifying Progression Rates in Early‐Stage Type 1 Diabetes
- Association Between Orforglipron and Blood Pressure in Adults With Obesity With or Without Type 2 Diabetes: Post Hoc Analyses From ATTAIN‐1 and ATTAIN‐2 Trials
- Cardiovascular Outcomes in Semaglutide Versus Tirzepatide Users With Obesity and Atherosclerotic Disease: A Target Trial Emulation
- Daily Steps and Heart Rate After Semaglutide or Tirzepatide Initiation: An Apple HealthKit Cohort in All of Us